Detalhe da pesquisa
1.
Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysis.
Blood
; 140(24): 2584-2593, 2022 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36122385
2.
CAR-HEMATOTOX: a model for CAR T-cell-related hematologic toxicity in relapsed/refractory large B-cell lymphoma.
Blood
; 138(24): 2499-2513, 2021 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34166502
3.
The CAR-HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL.
Am J Hematol
; 98(11): 1699-1710, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37584447
4.
First-line treatment of double-hit and triple-hit lymphomas: Survival and tolerance data from a retrospective multicenter French study.
Am J Hematol
; 96(3): 302-311, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33306213
5.
Clinical characteristics and outcomes of relapsed follicular lymphoma after autologous stem cell transplantation in the rituximab era.
Hematol Oncol
; 38(2): 137-145, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31953963
6.
Commercial anti-CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center.
Am J Hematol
; 95(11): 1324-1333, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32744738
7.
Approach to the diagnosis and treatment of high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements.
Blood
; 129(3): 280-288, 2017 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27821509
8.
Refractory diffuse large B-cell lymphoma after first-line immuno-CT: Treatment options and outcomes.
Hematol Oncol
; 2018 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29722049
9.
COVID-19: What type of cytokine storm are we dealing with?
J Med Virol
; 93(1): 197-198, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32681651
10.
B-cell malignancies and COVID-19: a narrative review.
Clin Microbiol Infect
; 29(3): 332-337, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36336236
11.
[Antibody drug conjugates (ADC) and bispecific antibodies in oncology - report of the 2022 Saint Louis day]. / Anticorps monoclonaux conjugués et bispécifiques en cancérologie compte rendu de la Journée de Saint Louis 2022.
Bull Cancer
; 110(12): 1343-1351, 2023 Dec.
Artigo
em Francês
| MEDLINE | ID: mdl-37827964
12.
HLA-DR expression on monocytes and outcome of anti-CD19 CAR T-cell therapy for large B-cell lymphoma.
Blood Adv
; 7(5): 744-755, 2023 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35439292
13.
The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma.
J Hematol Oncol
; 16(1): 88, 2023 07 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37525244
14.
Nonrelapse mortality after CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry.
Blood Adv
; 7(21): 6589-6598, 2023 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37672383
15.
High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma.
Blood Adv
; 7(23): 7331-7345, 2023 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37862676
16.
The burden of SARS-CoV-2 in patients receiving chimeric antigen receptor T cell immunotherapy: everything to lose.
Expert Rev Anti Infect Ther
; 20(9): 1155-1162, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35838042
17.
Lymphomas associated with Epstein-Barr virus infection in 2020: Results from a large, unselected case series in France.
EClinicalMedicine
; 54: 101674, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36204003
18.
Plasticity of Mature B Cells Between Follicular and Classic Hodgkin Lymphomas: A Series of 22 Cases Expanding the Spectrum of Transdifferentiation.
Am J Surg Pathol
; 46(1): 58-70, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34265801
19.
Rituximab in combination with adapted-dose of ifosfamide and etoposide as salvage treatment in elderly refractory/relapsed diffuse large B-cell lymphoma patients non-candidate for high dose therapy: a retrospective study.
Leuk Lymphoma
; 63(3): 599-607, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34720034
20.
A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma.
Nat Med
; 28(10): 2145-2154, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36138152